Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    50.0%

    Based on 1 completed trials

    Completion Rate
    50%(1/2)
    Active Trials
    0(0%)
    Results Posted
    0%(0 trials)
    Terminated
    1(33%)

    Phase Distribution

    Phase 2
    1
    33%
    Not Applicable
    2
    67%

    Phase Distribution

    0

    Early Stage

    1

    Mid Stage

    0

    Late Stage

    Phase Distribution3 total trials
    Phase 2Efficacy & side effects
    1(33.3%)
    N/ANon-phased studies
    2(66.7%)

    Highest Phase Reached

    Phase 2

    Trial Status & Enrollment

    Completion Rate

    50.0%

    1 of 2 finished

    Non-Completion Rate

    50.0%

    1 ended early

    Currently Active

    0

    trials recruiting

    Total Trials

    3

    all time

    Status Distribution
    Completed(1)
    Terminated(1)
    Other(1)

    Detailed Status

    Terminated1
    Completed1
    unknown1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    3
    Active
    0
    Success Rate
    50.0%
    Most Advanced
    Phase 2

    Trials by Phase

    Phase 21 (33.3%)
    N/A2 (66.7%)

    Trials by Status

    terminated133%
    completed133%
    unknown133%

    Recent Activity

    0 active trials
    Showing 3 of 3
    terminatednot_applicable

    Diagnostic Study to Identify Sentinel Lymph Nodes in Women With Stage I or Stage II Breast Cancer

    NCT00003654
    unknownphase_2

    Sentinel Lymph Node Biopsy to Assess Axillary Lymph Nodes in Women With Stage I or Stage II Breast Cancer

    NCT00005821
    completednot_applicable

    Technetium Tc 99m Sulfur Colloid and Blue Dye In Detecting Sentinel Lymph Nodes in Patients With Breast Cancer

    NCT00052676

    Clinical Trials (3)

    Showing 3 of 3 trials
    NCT00003654Not Applicable

    Diagnostic Study to Identify Sentinel Lymph Nodes in Women With Stage I or Stage II Breast Cancer

    Terminated
    NCT00005821Phase 2

    Sentinel Lymph Node Biopsy to Assess Axillary Lymph Nodes in Women With Stage I or Stage II Breast Cancer

    Unknown
    NCT00052676Not Applicable

    Technetium Tc 99m Sulfur Colloid and Blue Dye In Detecting Sentinel Lymph Nodes in Patients With Breast Cancer

    Completed

    All 3 trials loaded

    Drug Details

    Intervention Type
    Drug
    Total Trials
    3